Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

Stramsen Biotech Inc: Valuation, Funding & Investors

6200 Savoy Dr Suite #1202 - 12th Floor Houston, Texas 77036, UShttps://www.stramsenbiotech.com/Therapeutics

Stramsen Biotech Inc is an emerging leader in the plant-based biopharmaceutical industry, focused on accelerating clinical development and growth. The company leverages innovative plant-based technologies to advance its biopharmaceutical initiatives, aiming to enhance its position in the market through strategic investments and recruitment of experienced management and scientific teams.

Leadership & Board

Current Number of Employees: 6
Current LinkedIn Followers: 416

Latest Estimated Valuation

Total Amount Raised: $50M
Total Funding Rounds: 2
Latest Funding Amount: $25M
Latest Funding Round: Series B

Employee Trend

Stramsen Biotech Inc had 6 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.

6Latest Employee Count

0(0.00%)Week-Over-Week Change

Social Trend

Stramsen Biotech Inc had 416 followers as of October 26, 2026. The number of followers increased by 0 (0.00%) week-over-week.

416Latest Followers Count

0(0.00%)Week-Over-Week Change

Funding Round

Funding Date	Funding Round	Amount Raised	Post-Money Valuation
May 07, 2025	Series B	$25.00M	―
Apr 07, 2025	Investment	$25.00M	―

Investors

Investor Name	Funding Round
Global Emerging Markets	Series B
GEM Global Yield LLC SCS	Investment

Similar Companies

A snapshot of private companies similar to Stramsen Biotech Inc, helping you discover and navigate related company profiles.

Pieces Technologies

Zucara Therapeutics Inc

Related News and Analysis

Stramsen Biotech Advances SBX-1977 Toward IND as It Bolsters Finance Leadership for Capital Markets Push

Stramsen Biotech Advances SBX-1977 Toward IND as It Bolsters Finance Leadership for Capital Markets Push

New updates have been reported about Stramsen Biotech Inc. Stramsen Biotech Inc. has received written feedback from the U.S. Food and Drug Administration on its Pre‑IND package for SBX‑1977, its

4M ago

Stramsen Biotech Valued at $19 Billion as It Prepares Capital Markets Push and FDA Milestones

Stramsen Biotech Valued at $19 Billion as It Prepares Capital Markets Push and FDA Milestones

New updates have been reported about Stramsen Biotech Inc. Stramsen Biotech Inc. has been independently valued at approximately $19 billion by Stonebridge Advisory Inc., a California-based appraisal firm, reflecting the

7M ago

Fathom Therapeutics Names New CSO to Drive Post–Series A Pipeline Build-Out

Fathom Therapeutics Names New CSO to Drive Post–Series A Pipeline Build-Out

New updates have been reported about Fathom Therapeutics. Fathom Therapeutics has appointed Bret Williams, Ph.D., as Chief Scientific Officer, positioning the company to convert its physics- and AI-driven Microcosmos platform

1h ago

Ondo Finance Extends Intelligent Portfolios to Solana After $40M Launch Surge

Ondo Finance Extends Intelligent Portfolios to Solana After $40M Launch Surge

New updates have been reported about Ondo Finance. Ondo Finance has expanded its Ondo Intelligent Portfolios product suite to the Solana blockchain, making all seven professionally curated, onchain portfolios accessible

1h ago

Armadin Adds Former NSA Director Paul Nakasone to Board to Bolster Autonomous Cyber Strategy

Armadin Adds Former NSA Director Paul Nakasone to Board to Bolster Autonomous Cyber Strategy

New updates have been reported about Armadin. Armadin has strengthened its governance and strategic depth by appointing four-star General Paul M. Nakasone, U.S. Army (Ret.), former Director of the National

1h ago

MasterClass Expands Certificate Portfolio With Uber-Led Growth Strategy Course

MasterClass Expands Certificate Portfolio With Uber-Led Growth Strategy Course

New updates have been reported about MasterClass. MasterClass has launched a new Certificate course, “Growth Strategy: Find the Problem. Grow the Business.,” developed in partnership with Uber and taught by

1h ago

Cresta Launches Self-Service AI Agent Platform to Put Developers in Control

Cresta Launches Self-Service AI Agent Platform to Put Developers in Control

New updates have been reported about Cresta. Cresta has opened its customer experience AI platform to full self-service, enabling enterprise developers to design, test, deploy, and refine customer-facing AI agents

1h ago

Tovala Launches Blueprint-Certified Longevity Meal Line to Deepen Health-Focused Positioning

Tovala Launches Blueprint-Certified Longevity Meal Line to Deepen Health-Focused Positioning

New updates have been reported about Tovala. Tovala has introduced a new Longevity Meals line, developed in partnership with Bryan Johnson’s Blueprint, positioning the company more squarely in the fast-growing

2h ago

ABCS Insights Taps Veteran Product Leader Marc Ryan to Drive Full-Funnel Measurement Strategy

ABCS Insights Taps Veteran Product Leader Marc Ryan to Drive Full-Funnel Measurement Strategy

New updates have been reported about ABCS Insights. ABCS Insights has appointed measurement veteran Marc Ryan as chief product officer, positioning the company to scale its full-funnel advertising effectiveness platform

2h ago

Anterior Open-Sources Symbolic Reasoning Framework to Tighten Policy Compliance in Healthcare AI

Anterior Open-Sources Symbolic Reasoning Framework to Tighten Policy Compliance in Healthcare AI

New updates have been reported about Anterior. Anterior has released an open-source symbolic reasoning framework built on Symbolic Reasoning Graphs (SRGs) to make clinical policy adherence by AI systems more

2h ago